Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES FOURIERTRANSFORM
Mandate

VINGE ADVISES FOURIERTRANSFORM

June 17, 2015

Vinge has advised Fouriertransform in connection with its investment in Lamera AB. Lamera develops a light-weight material based on state of the art lamination technology and the result is a unique, patented and formable composite which is both light and durable.

Vinge’s team consisted of Magnus Pauli, Karin Wisenius, Hampus Wikerståhl and Johanna Nyström.

Related

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025